Northern Trust Receives Approval for New EU Banking Branch in Ireland June 15, 2026 Northern Trust announced today that it has received a licence from the Central Bank of Ireland for the establishment of The Northern Trust Company, Ireland Branch (Ireland Branch). This new banking branch will provide a range of custodial, banking and capital markets services, including domestically regulated banking services for Ireland-domiciled clients. Its activities will complement [...]
COOCON Joins Global AI Agent Foundation AAIF to Advance AI Agent Payments and MCP-Based Data Business June 12, 2026 - Establishes a global collaborative network with more than 180 companies, including OpenAI, Google, Anthropic, and Microsoft - Joins discussions on AI agent payment and MCP data standards, accelerating its expansion into the global payment and data markets
ŌURA Signs England Football Legends Harry Kane and Declan Rice as Global Brand Ambassadors June 11, 2026 The partnerships will see the football stars using Oura Ring 5 for its superior accuracy and discreet design, supporting their performance, resilience and recovery during the upcoming football season
Xsolla to Meet With Mobile Game Developers and Publishers at Pocket Gamer Connects Barcelona 2026 June 11, 2026 Company to Highlight Direct-to-Consumer Web Shop Solutions and Global Payments Infrastructure at Europe's Premier Mobile Gaming Conference
Kraken Launches Autonomous Agents for Utility Customer Service Built in Partnership with Sierra June 11, 2026 Developed in partnership with Sierra, Autonomous Agents combines Kraken’s utility AI-enabled operating system, unified data model and workflow engine with Sierra’s AI customer experience platform Built on Kraken’s Utility-Grade AI® and AI access layer, Autonomous Agents help customer service teams design, test and deploy agents for energy and utility-specific service journeys Autonomous Agents are already proven in enterprise-scale deployment, going live in four weeks and scaling to cover 1.3 million customer accounts at a major energy utility
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera June 11, 2026 New analyses from the Phase 1 SANRECO study demonstrate potential improvements in PV symptoms and quality-of-life Follow-up data show substantial reductions in phlebotomy use persisting after final dose Phase 2 SANRECO study evaluating Q6W and Q12W dosing remains on-track for topline results in August 2026
Harley Street Health District Releases First Annual Impact Report June 11, 2026 New report demonstrates annual market value of Harley Street Health District is £1.85 billion, approximately £143 million growth in 12 months Estimated annual contribution to the UK economy is £810 million, predicted to reach £911 million in the next year Investment in HealthTech property in the District last year totalled £42.4 million from The Howard de Walden Estate
Northern Trust Asset Management Launches Sustainable Multifactor Funds June 11, 2026 UCITS Funds Provide Climate Focused Core Equities Strategies
Comrade Trustee Services goes live with Smartstream’s Air, the AI reconciliation and data automation solution June 11, 2026 Key Facts Comrade Trustee Services is live on Smartstream’s Air for automated reconciliations with fully integrated workflows. The implementation replaces highly manual, spreadsheet-driven processes and complex file handling with a single-click, straight-through AI-driven workflow. This will improve accuracy, control and operational efficiency. Processing time has been reduced from up to eight hours to under five minutes, with additional scalability for complex file types, formats and reconciliation logic.
Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer June 11, 2026 Anocca AB (‘Anocca’ or the ‘Company’), a clinical-stage biotechnology company developing advanced T-cell immunotherapies, today announced the successful dosing of the first patients across multiple clinical sites with ANOC-001, a novel T cell receptor-modified T cell therapy (TCR-T)[1] targeting KRAS G12V mutations in an aggressive form of pancreatic cancer. ANOC-001 is the first product to [...]
